Related references
Note: Only part of the references are listed.Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
Marco Trevisan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry
Gianluigi Savarese et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure
Gianluigi Savarese et al.
HEART (2018)
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction
Gianluigi Savarese et al.
JOURNAL OF CARDIAC FAILURE (2018)
Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
Gianluigi Savarese et al.
JACC-HEART FAILURE (2018)
Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure
O. Ola Vedin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
A comprehensive population-based characterization of heart failure with mid-range ejection fraction
Angela S. Koh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction A Nationwide Cohort Study
Ola Vedin et al.
CIRCULATION-HEART FAILURE (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial
Scott D. Solomon et al.
CIRCULATION-HEART FAILURE (2016)
Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction
Gianluigi Savarese et al.
CIRCULATION-HEART FAILURE (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012
Tonje Thorvaldsen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure
Crystel M. Gijsberts et al.
HEART (2016)
Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)
Abel Makubi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Heart Failure With Mid-Range Ejection Fraction-New Opportunities
Lars H. Lund
JOURNAL OF CARDIAC FAILURE (2016)
Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study
Magnus Edner et al.
EUROPEAN HEART JOURNAL (2015)
Registry-based randomized clinical trials-a new clinical trial paradigm
Stefan James et al.
NATURE REVIEWS CARDIOLOGY (2015)
Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction
Ole Frobert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson et al.
BMC PUBLIC HEALTH (2011)
Heart failure registry: a valuable tool for improving the management of patients with heart failure
Asa Jonsson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Death in Heart Failure A Community Perspective
Danielle M. Henkel et al.
CIRCULATION-HEART FAILURE (2008)
The validity of a diagnosis of heart failure in a hospital discharge register
E Ingelsson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables
J Juenger et al.
HEART (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
